The aetiology of Rett syndrome (RTT), a rare neurodevelopmental disorder (discussed later), is mainly based on de novo mutations of the methyl CpG binding protein 2 (MECP2) gene, which encodes for a transcription factor mediating gene regulation [92]. This evidence concerns the gene MECP2 and neurodevelopmental disorder.